Browse > Article
http://dx.doi.org/10.5483/BMBRep.2021.54.12.165

Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas: a systematic analysis and review  

Cho, Hee Jin (Department of Biomedical Convergence Science and Technology, Kyungpook National University)
Koo, JaeHyung (Department of New Biology, DGIST)
Publication Information
BMB Reports / v.54, no.12, 2021 , pp. 601-607 More about this Journal
Abstract
Odorant receptors (ORs) account for about 60% of all human G protein-coupled receptors (GPCRs). OR expression outside of the nose has functions distinct from odor perception, and may contribute to the pathogenesis of disorders including brain diseases and cancers. Glioma is the most common adult malignant brain tumor and requires novel therapeutic strategies to improve clinical outcomes. Here, we outlined the expression of brain ORs and investigated OR expression levels in glioma. Although most ORs were not ubiquitously expressed in gliomas, a subset of ORs displayed glioma subtype-specific expression. Moreover, through systematic survival analysis on OR genes, OR51E1 (mouse Olfr558) was identified as a potential biomarker of unfavorable overall survival, and OR2C1 (mouse Olfr15) was identified as a potential biomarker of favorable overall survival in isocitrate dehydrogenase (IDH) wild-type glioma. In addition to transcriptomic analysis, mutational profiles revealed that somatic mutations in OR genes were detected in > 60% of glioma samples. OR5D18 (mouse Olfr1155) was the most frequently mutated OR gene, and OR5AR1 (mouse Olfr1019) showed IDH wild-type-specific mutation. Based on this systematic analysis and review of the genomic and transcriptomic profiles of ORs in glioma, we suggest that ORs are potential biomarkers and therapeutic targets for glioma.
Keywords
Glioma; GPCR; Odorant receptor; OR51E1; OR51E2;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Hakak Y, Shrestha D, Goegel MC, Behan DP and Chalmers DT (2003) Global analysis of G-protein-coupled receptor signaling in human tissues. FEBS Lett 550, 11-17   DOI
2 Conzelmann S, Levai O, Bode B et al (2000) A novel brain receptor is expressed in a distinct population of olfactory sensory neurons. Eur J Neurosci 12, 3926-3934   DOI
3 Raming K, Konzelmann S and Breer H (1998) Identification of a novel G-protein coupled receptor expressed in distinct brain regions and a defined olfactory zone. Recept Channels 6, 141-151
4 Hauser AS, Attwood MM, Rask-Andersen M, Schioth HB and Gloriam DE (2017) Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 16, 829-842   DOI
5 Wu A, Maxwell R, Xia Y et al (2019) Combination antiCXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment. J Neurooncol 143, 241-249   DOI
6 Lin MS, Chiu IH and Lin CC (2021) Ultrarapid inflammation of the olfactory bulb after spinal cord injury: protective effects of the granulocyte colony-stimulating factor on early neurodegeneration in the brain. Front Aging Neurosci 13, 701702   DOI
7 Weber M, Pehl U, Breer H and Strotmann J (2002) Olfactory receptor expressed in ganglia of the autonomic nervous system. J Neurosci Res 68, 176-184   DOI
8 Zhang X, Rogers M, Tian H et al (2004) High-throughput microarray detection of olfactory receptor gene expression in the mouse. Proc Natl Acad Sci U S A 101, 14168-14173   DOI
9 Ansoleaga B, Garcia-Esparcia P, Llorens F, Moreno J, Aso E and Ferrer I (2013) Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience 248, 369-382   DOI
10 Grison A, Zucchelli S, Urzi A et al (2014) Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules. BMC Genomics 15, 729   DOI
11 Lee N, Sa M, Hong YR, Lee CJ and Koo J (2018) Fatty acid increases cAMP-dependent lactate and MAO-B-dependent GABA production in mouse astrocytes by activating a galphas protein-coupled receptor. Exp Neurobiol 27, 365- 376   DOI
12 Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987-996   DOI
13 Zhou Y, Larsen PH, Hao C and Yong VW (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277, 49481-49487   DOI
14 Di Pizio A, Behrens M and Krautwurst D (2019) Beyond the flavour: the potential druggability of chemosensory G protein-coupled receptors. Int J Mol Sci 20, 1402   DOI
15 Massberg D and Hatt H (2018) Human olfactory receptors: novel cellular functions outside of the nose. Physiol Rev 98, 1739-1763   DOI
16 Bjarnadottir TK, Gloriam DE, Hellstrand SH, Kristiansson H, Fredriksson R and Schioth HB (2006) Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 88, 263-273   DOI
17 Sriram K, Moyung K, Corriden R, Carter H and Insel PA (2019) GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors. PLoS Biol 17, e3000434   DOI
18 Kalra S, Mittal A, Gupta K et al (2020) Analysis of single-cell transcriptomes links enrichment of olfactory receptors with cancer cell differentiation status and prognosis. Commun Biol 3, 506   DOI
19 Weber L, Massberg D, Becker C et al (2018) Olfactory receptors as biomarkers in human breast carcinoma tissues. Front Oncol 8, 33   DOI
20 Schwartzbaum JA, Fisher JL, Aldape KD and Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2, 494-503; quiz 491 p following 516   DOI
21 Brennan CW, Verhaak RG, McKenna A et al (2013) The somatic genomic landscape of glioblastoma. Cell 155, 462-477   DOI
22 Ceccarelli M, Barthel FP, Malta TM et al (2016) Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550-563   DOI
23 Cho T, Lee C, Lee N, Hong YR and Koo J (2019) Small-chain fatty acid activates astrocytic odorant receptor Olfr920. Biochem Biophys Res Commun 510, 383-387   DOI
24 Cancer Genome Atlas Research N, Brat DJ, Verhaak RG et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372, 2481-2498   DOI
25 Kang N and Koo J (2012) Olfactory receptors in non-chemosensory tissues. BMB Rep 45, 612-622   DOI
26 Byrne KF, Pal A, Curtin JF, Stephens JC and Kinsella GK (2021) G-protein-coupled receptors as therapeutic targets for glioblastoma. Drug Discov Today 26, 2858-2870   DOI
27 HGNC Database, HUGO Gene Nomenclature Committee (HGNC), European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom www.genenames.org. November, 2021
28 Iiri T, Farfel Z and Bourne HR (1998) G-protein diseases furnish a model for the turn-on switch. Nature 394, 35-38   DOI
29 Lee N, Jae Y, Kim M et al (2020) A pathogen-derived metabolite induces microglial activation via odorant receptors. FEBS J 287, 3841-3870   DOI
30 Ferrer I, Garcia-Esparcia P, Carmona M et al (2016) Olfactory receptors in non-chemosensory organs: the nervous system in health and disease. Front Aging Neurosci 8, 163
31 Insel PA, Sriram K, Wiley SZ et al (2018) GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets. Front Pharmacol 9, 431   DOI
32 Wu V, Yeerna H, Nohata N et al (2019) Illuminating the Onco-GPCRome: novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy. J Biol Chem 294, 11062-11086   DOI
33 O'Hayre M, Vazquez-Prado J, Kufareva I et al (2013) The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 13, 412-424   DOI
34 Gaudel F, Stephan D, Landel V, Sicard G, Feron F and Guiraudie-Capraz G (2019) Expression of the cerebral olfactory receptors Olfr110/111 and Olfr544 is altered during aging and in Alzheimer's disease-like mice. Mol Neurobiol 56, 2057-2072   DOI
35 Regard JB, Sato IT and Coughlin SR (2008) Anatomical profiling of G protein-coupled receptor expression. Cell 135, 561-571   DOI
36 Otaki JM, Yamamoto H and Firestein S (2004) Odorant receptor expression in the mouse cerebral cortex. J Neurobiol 58, 315-327   DOI
37 Feldmesser E, Olender T, Khen M, Yanai I, Ophir R and Lancet D (2006) Widespread ectopic expression of olfactory receptor genes. BMC Genomics 7, 121   DOI
38 Garcia-Esparcia P, Schluter A, Carmona M et al (2013) Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J Neuropathol Exp Neurol 72, 524-539   DOI
39 Masjedi S, Zwiebel LJ and Giorgio TD (2019) Olfactory receptor gene abundance in invasive breast carcinoma. Sci Rep 9, 13736   DOI
40 Ranzani M, Iyer V, Ibarra-Soria X et al (2017) Revisiting olfactory receptors as putative drivers of cancer. Wellcome Open Res 2, 9   DOI
41 Vadevoo SMP, Gunassekaran GR, Lee C et al (2021) The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages. Proc Natl Acad Sci U S A 118, e2102434118   DOI
42 Sa JK, Chang N, Lee HW et al (2020) Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. Genome Biol 21, 216   DOI
43 Serizawa S, Miyamichi K and Sakano H (2005) Negative feedback regulation ensures the one neuron-one receptor rule in the mouse olfactory system. Chem Senses 30 Suppl 1, i99-i100   DOI
44 Flegel C, Manteniotis S, Osthold S, Hatt H and Gisselmann G (2013) Expression profile of ectopic olfactory receptors determined by deep sequencing. PLoS One 8, e55368   DOI
45 Wang Q, Hu B, Hu X et al (2018) Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 33, 152   DOI
46 Yuan Y, Qi P, Xiang W, Yanhui L, Yu L and Qing M (2020) Multi-omics analysis reveals novel subtypes and driver genes in glioblastoma. Front Genet 11, 565341   DOI
47 Wang Q, He Z and Chen Y (2019) Comprehensive analysis reveals a 4-gene signature in predicting response to temozolomide in low-grade glioma patients. Cancer Control 26, 1073274819855118
48 Hanchate NK, Kondoh K, Lu Z et al (2015) Single-cell transcriptomics reveals receptor transformations during olfactory neurogenesis. Science 350, 1251-1255   DOI
49 Pappula AL, Rasheed S, Mirzaei G, Petreaca RC and Bouley RA (2021) A genome-wide profiling of glioma patients with an IDH1 mutation using the catalogue of somatic mutations in cancer database. Cancers (Basel) 13, 4299   DOI
50 Aquilanti E, Miller J, Santagata S, Cahill DP and Brastianos PK (2018) Updates in prognostic markers for gliomas. Neuro Oncol 20, vii17-vii26   DOI
51 Cui T, Tsolakis AV, Li SC et al (2013) Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas. Eur J Endocrinol 168, 253-261   DOI
52 Jimenez RC, Casajuana-Martin N, Garcia-Recio A et al (2021) The mutational landscape of human olfactory G protein-coupled receptors. BMC Biol 19, 21   DOI
53 Zhao H, Du P, Peng R et al (2021) Long noncoding RNA OR7E156P/miR-143/HIF1A axis modulates the malignant behaviors of glioma cell and tumor growth in mice. Front Oncol 11, 690213   DOI
54 Hamm HE (1998) The many faces of G protein signaling. J Biol Chem 273, 669-672   DOI
55 Trimmer C, Keller A, Murphy NR et al (2019) Genetic variation across the human olfactory receptor repertoire alters odor perception. Proc Natl Acad Sci U S A 116, 9475-9480   DOI
56 Sriram K and Insel PA (2018) G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs? Mol Pharmacol 93, 251-258   DOI
57 Ansoleaga B, Garcia-Esparcia P, Pinacho R, Haro JM, Ramos B and Ferrer I (2015) Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia. J Psychiatr Res 60, 109-116   DOI
58 Zhao J, Chen AX, Gartrell RD et al (2019) Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nat Med 25, 462-469   DOI
59 Wen PY and Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359, 492-507   DOI
60 Fredriksson R, Lagerstrom MC, Lundin LG and Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63, 1256-1272   DOI
61 Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23, 1231-1251   DOI
62 Nordstrom KJ, Sallman Almen M, Edstam MM, Fredriksson R and Schioth HB (2011) Independent HHsearch, Needleman--Wunsch-based, and motif analyses reveal the overall hierarchy for most of the G protein-coupled receptor families. Mol Biol Evol 28, 2471-2480   DOI